Clinical evidence demonstrates that subsidized fruit and vegetable programs yield quantifiable health improvements across diverse populations. Participants receiving produce vouchers or prescriptions showed reduced blood pressure, improved glycemic control, and enhanced dietary quality scores compared to control groups. Effect sizes were particularly pronounced among low-income households and individuals with diabetes or hypertension. These interventions represent a convergence of food security policy and precision nutrition, addressing both access barriers and behavioral change simultaneously. The approach builds on decades of research linking produce consumption to reduced cardiovascular mortality and cancer incidence, but operationalizes this knowledge through healthcare delivery systems rather than traditional public health messaging. While promising, most studies remain short-term with limited follow-up data on sustained behavior change. The model also faces scalability challenges given food distribution infrastructure requirements and reimbursement complexities. However, the measurable clinical outcomes suggest these programs could complement pharmaceutical interventions for metabolic disorders, potentially reducing healthcare costs while addressing upstream determinants of chronic disease. This represents a shift toward treating nutrition deficiency as a medical condition warranting insurance coverage.